Incyte Financial Statements (INCY)

Incytesmart-lab.ru %   2023Q2 2023Q3 2023Q4 2023Q4 2024Q1   LTM ?
Report date 01.08.2023 31.10.2023 31.12.2023 16.02.2024 30.04.2024   30.04.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 954.6 919.0 1 013 1 013 880.9   3 827
Operating Income, bln rub 193.8 214.7 187.3 187.3 91.9   681.1
EBITDA, bln rub ? 265.1 260.7 274.5 274.5 158.1   967.8
Net profit, bln rub ? 203.5 171.3 201.1 201.1 169.5   743.0
OCF, bln rub ? 306.5 147.8 147.7 147.7 218.8   662.1
CAPEX, bln rub ? 7.34 11.0 2.27 2.27 9.55   25.1
FCF, bln rub ? 299.2 136.9 145.5 145.5 209.3   637.0
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 684.1 644.7 741.3 741.3 728.5   2 856
Cost of production, bln rub 68.3 60.1 69.8 69.8 61.0   260.7
R&D, bln rub 400.8 375.7 444.5 444.5 429.3   1 694
Interest expenses, bln rub 0.655 0.623 0.804 0.804 0.430   2.66
Assets, bln rub 6 208 6 388 6 782 6 782 7 136   7 136
Net Assets, bln rub ? 4 741 4 931 5 190 5 190 5 394   5 394
Debt, bln rub 39.7 31.9 38.3 38.3 37.4   37.4
Cash, bln rub 3 423 3 516 3 656 3 656 3 851   3 851
Net debt, bln rub -3 384 -3 485 -3 618 -3 618 -3 813   -3 813
Ordinary share price, rub 62.3 57.8 62.8 62.8 57.0   54.0
Number of ordinary shares, mln 223.2 224.1 226.1 224.2 224.5   224.5
Market cap, bln rub 13 897 12 945 14 198 14 079 12 789   12 115
EV, bln rub ? 10 514 9 460 10 581 10 461 8 976   8 302
Book value, bln rub 4 450 4 647 4 911 4 911 5 121   5 121
EPS, rub ? 0.91 0.76 0.89 0.90 0.76   3.31
FCF/share, rub 1.34 0.61 0.64 0.65 0.93   2.84
BV/share, rub 19.9 20.7 21.7 21.9 22.8   22.8
EBITDA margin, % ? 27.8% 28.4% 27.1% 27.1% 18.0%   25.3%
Net margin, % ? 21.3% 18.6% 19.8% 19.8% 19.2%   19.4%
FCF yield, % ? 5.02% 4.37% 3.16% 3.19% 6.18%   5.26%
ROE, % ? 7.73% 8.62% 11.5% 11.5% 13.8%   13.8%
ROA, % ? 5.90% 6.65% 8.81% 8.81% 10.4%   10.4%
P/E ? 37.9 30.5 23.8 23.6 17.2   16.3
P/FCF 19.9 22.9 31.6 31.4 16.2   19.0
P/S ? 3.96 3.59 3.84 3.81 3.39   3.17
P/BV ? 3.12 2.79 2.89 2.87 2.50   2.37
EV/EBITDA ? 17.7 13.3 12.2 12.1 9.36   8.58
Debt/EBITDA -5.69 -4.90 -4.19 -4.19 -3.98   -3.94
R&D/CAPEX, % 5 462% 3 423% 19 607% 19 607% 4 495%   6 760%
CAPEX/Revenue, % 0.77% 1.19% 0.22% 0.22% 1.08%   0.65%
Incyte shareholders